10.00 am to 1.00 pm
7 April 2020
Available on ZOOM via the link:
Adapting to Covid-19:
Defending the Public Interest in Vaccine and Medical Development
COVID-19 has shone a light on a fatal weakness in our health system: the profit-driven pharmaceutical innovation model that we rely upon to develop life-saving vaccines and medicines.
This global health emergency should bring countries, international organizations, NGOs, investors and industry together to agree on a new social contract whereby industry serves the public interest rather than shareholder profit. Governments must use their power to direct and control medical development and to ensure that products are accessible to the public- who will have contributed substantially to early research.
Drug markets will not be fixed by the pharmaceutical industry and they most certainly will not fix themselves.
Web Conference opening by Ms. Emily O’Reilly EU Ombudsman
Prof Sam McConkey, Professor Infectious Diseases, RCSI
Dr Ellen ‘t Hoen, University of Groningen
Dr. Gaelle Kirkorian, Médecins Sans Frontières
Mr Darren O Rourke, TD and PhD Scholar
Mr. Diarmiad McDonald, Just Treatment
Dr. Andrew Hill, University of Liverpool
Moderator: Susan Mitchell, Deputy Editor, Business Post
Keep an eye out on Twitter, Eventbrite for updates
This conference is organised by AMI, a volunteer group who campaign for a system of medical R&D which delivers equitable access to the medicines we need at a fair price globally. AMI is a membership group of Comhlámh